Someone alive will reach 150

David Sinclair of Harvard Medical School stands by his claim that the first 150-year-old has already been born. Children born today will see the 22nd century.

“Children born today are going to have access to technologies that we literally cannot even imagine now.”

Ovaries are everyone's problem

Neuroscientist Jennifer Garrison studies ovarian aging, and says the payoff is not limited to women. Differences between male and female bodies are where new medicines come from.

“When we miss female physiology, we've essentially left out half of the picture.”

Women fight viruses better

Female bodies tend to beat back viral infections more effectively than male ones. Nobody fully knows why, and cracking that would sharpen treatment for both sexes.

Generations behind, not years

Asked how far the field has come on sex differences, Garrison was blunt. The data gap and systemic research bias put medicine generations back, not decades.

“It's not years. It's not decades. It's generations behind in terms of the data.”

Built for the dying, not the living

Musely CEO Jack Jia expanded his company after watching his wife hunt for a melasma treatment. Skin and wellness conditions fall through the cracks of a system aimed at critical illness.

“The entire healthcare system is not designed to solve that problem; it's designed to solve that real sick person who is dying.”

The testing boom has a credibility problem

Scans and panels marketed for optimizing your lifespan are booming. Garrison says plenty of it is thin on evidence or flatly pseudoscientific, and shoppers cannot tell the difference.

“A lot of the products that are marketed are either poorly supported by evidence or outright pseudoscience.”

From too strict to too loose

Peptide injections and unproven drugs have moved from fringe to routine. Sinclair defends patient access when nothing else works, but thinks the pendulum has swung past sensible.

“That was too extreme in my view, but we've gone with the other extreme.”